Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Synonyms :
Class :
Indicated for Ventricular Arrhythmia
For undiluted solution: administer dose of 5 mg/kg intravenously via rapid injection in case of persistent arrhythmia, the dose can be raised up to 10 mg/kg and repeated as per need
For diluted solution for continuous suppression: administer 1 to 2 mg/min intravenously
Alternatively, administer 5 to 10 mg/kg intravenously over a minimum for 8 minutes every 6 hours
side effects of cardiac glycosides are increased by bretylium
side effects of cardiac glycosides are increased by bretylium
side effects of cardiac glycosides are increased by bretylium
When ponesimod is used together with bretylium, this leads to enhanced risk or seriousness of bradycardia
When bretylium is used together with givinostat, this leads to enhanced risk or seriousness of Qtc prolongation
bretylium: it may increase the risk of CNS depression
bretylium: it may increase the risk of CNS depression
bretylium: it may increase the risk of CNS depression
bretylium: it may increase the risk of CNS depression
bretylium: it may increase the risk of CNS depression
the therapeutic efficiency of bretylium can be reduced when taken with mofebutazone
the therapeutic activity of bretylium may be reduced
phentolamine: it may decrease the antihypertensive activities of bretylium